Therapy Cells Inc. (OTCMKTS:TCEL) Files An 8-K Other Events
ITEM 8.01 OTHER EVENTS
Company entered into a Consulting Agreement on September 29, 2019.
ITEM 9.01 FINANCIAL INFORMATION AND EXHIBITS
Exhibit 99.1 – Press Release
THERAPY CELLS INC Exhibit
EX-99.1 2 tcel_ex9901.htm PRESS RELEASE Exhibit 99.1 XTRA BITCOIN INC (TCEL) fka Therapy Cells,…
To view the full exhibit click
About Therapy Cells Inc. (OTCMKTS:TCEL)
Therapy Cells, Inc. is a development-stage company. The Company’s business operations consist of doing business in the cell repair and cell replacement for Equine stock. The Company is pursuing Food and Drug Administration (FDA) approval for existing and modified products to be used for the repair of the human body. The Company’s principal product relates to existing licenses held for cell repair and cell replacement of Equine stock.